Latest Strategic Partnership News

3D Energi Limited confirms final well locations and a September 2025 start for Phase 1 of its Otway Basin drilling program, with ConocoPhillips covering up to US$65 million of costs.

Bryah Resources’ subsidiary has acquired a 0.75% net smelter return royalty over key tenements in the Bryah Basin manganese project, streamlining the asset and enhancing future strategic options as the project advances towards production.

BCAL Diagnostics has secured a strategic partnership with Cancer Care Associates to fast-track the clinical adoption and revenue generation of its innovative BREASTEST plus™ breast cancer blood test starting FY2026.

Gold Hydrogen has attracted a $14.5 million strategic investment from global energy leaders Toyota, Mitsubishi Gas Chemical, and ENEOS Xplora, following promising drilling results in South Australia. The funds will accelerate exploration and commercialisation of natural hydrogen and helium resources.

Yojee Limited has successfully raised $5.4 million through an oversubscribed placement, fueling development of its MOSAIC freight forwarding platform and expansion across the Asia Pacific region.

Blackstone Minerals has raised $22.6 million through a heavily oversubscribed placement led by Macquarie Bank, fueling a major drilling program at its Mankayan Copper-Gold Project in the Philippines. The capital raise follows a transformative merger and signals strong institutional confidence in the company’s growth strategy.

SportsHero Limited has inked major partnerships with leading Southeast Asian telcos, including a US$1 million contract with the Philippines’ PLDT, to expand its cloud-based gaming platform across the region.

BPH Global has launched a focused R&D collaboration with Temasek Polytechnic to develop seaweed-based bio-stimulants aimed at boosting growth and yields in Southeast Asia's oil palm and rice sectors. Early talks are also underway for a production facility in Indonesia to commercialize these innovations.

Vitasora Health has secured approximately A$11 million in capital to accelerate its expansion in the US remote patient monitoring market, highlighted by an upgraded contract with TPAC covering 15,000 patients. The company targets a USD 18 million annual recurring revenue run-rate by late 2026.

Prescient Therapeutics has opened a Share Purchase Plan to raise up to $7 million, offering shareholders discounted shares to fund the Phase 2 development of its targeted cancer therapy PTX-100.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

Emperor Energy secures independent validation of its Judith Gas Field resources, boosting unrisked prospective volumes to 1.86 trillion cubic feet and setting sights on a mid-2026 appraisal well to advance development.